These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34167520)

  • 1. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Stokwiszewski J; Zdrojewski T; Rutkowski M; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Sci Rep; 2023 Oct; 13(1):17252. PubMed ID: 37828071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study.
    Kalarus Z; Średniawa B; Mitręga K; Wierucki Ł; Sokal A; Lip G; Bandosz P; Stokwiszewski J; Boidol J; Zieleniewicz P; Rutkowski M; Kaźmierczak J; Opolski G; Grodzicki T; Zdrojewski T
    Kardiol Pol; 2023; 81(1):14-21. PubMed ID: 36043418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial.
    Steinhubl SR; Waalen J; Edwards AM; Ariniello LM; Mehta RR; Ebner GS; Carter C; Baca-Motes K; Felicione E; Sarich T; Topol EJ
    JAMA; 2018 Jul; 320(2):146-155. PubMed ID: 29998336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.
    Halcox JPJ; Wareham K; Cardew A; Gilmore M; Barry JP; Phillips C; Gravenor MB
    Circulation; 2017 Nov; 136(19):1784-1794. PubMed ID: 28851729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights From Patients at Risk Monitored Long Term With an Implantable Loop Recorder.
    Diederichsen SZ; Haugan KJ; Kronborg C; Graff C; Højberg S; Køber L; Krieger D; Holst AG; Nielsen JB; Brandes A; Svendsen JH
    Circulation; 2020 May; 141(19):1510-1522. PubMed ID: 32114796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
    Heo NJ; Rhee SY; Waalen J; Steinhubl S
    Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation-Compliance and ease of use in an ambulatory elderly population.
    Fredriksson T; Kemp Gudmundsdottir K; Frykman V; Friberg L; Al-Khalili F; Engdahl J; Svennberg E
    Clin Cardiol; 2020 Apr; 43(4):355-362. PubMed ID: 31917467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
    Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
    Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF).
    Turakhia MP; Ullal AJ; Hoang DD; Than CT; Miller JD; Friday KJ; Perez MV; Freeman JV; Wang PJ; Heidenreich PA
    Clin Cardiol; 2015 May; 38(5):285-92. PubMed ID: 25873476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study.
    Mitrega K; Lip GYH; Sredniawa B; Sokal A; Streb W; Przyludzki K; Zdrojewski T; Wierucki L; Rutkowski M; Bandosz P; Kazmierczak J; Grodzicki T; Opolski G; Kalarus Z
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source during 3 Years of Prolonged Monitoring with an Implantable Loop Recorder.
    Kitsiou A; Rogalewski A; Kalyani M; Deelawar S; Tribunyan S; Greeve I; Minnerup J; Israel C; Schäbitz WR
    Thromb Haemost; 2021 Jun; 121(6):826-833. PubMed ID: 33401327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of atrial fibrillation identification using noninvasive long-term electrocardiographic monitoring system (NOMED-AF TECH).
    Mitręga K; Średniawa B; Sokal AYH; Lip G; Rewiuk K; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z; Streb W
    Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 36861462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
    Lubitz SA; Faranesh AZ; Selvaggi C; Atlas SJ; McManus DD; Singer DE; Pagoto S; McConnell MV; Pantelopoulos A; Foulkes AS
    Circulation; 2022 Nov; 146(19):1415-1424. PubMed ID: 36148649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent atrial fibrillation detected by home-monitoring: Cardiovascular disease and stroke prevention in patients with diabetes.
    Højager A; Tingsgaard JK; Andersen D; Søholm H; Taskiran M; Bock TG; Schoos MM
    J Diabetes Complications; 2020 Dec; 34(12):107711. PubMed ID: 32900590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact.
    Dilaveris PE; Kennedy HL
    Clin Cardiol; 2017 Jun; 40(6):413-418. PubMed ID: 28273368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study.
    Berge T; Lyngbakken MN; Ihle-Hansen H; Brynildsen J; Pervez MO; Aagaard EN; Vigen T; Kvisvik B; Christophersen IE; Steine K; Omland T; Smith P; Røsjø H; Tveit A
    BMJ Open; 2018 Aug; 8(7):e021704. PubMed ID: 30068617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.